| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.5 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.6 |